Company Search:
Advanced Search
Sponsored Links
Walvax Biotechnology Company Limited Company Snapshot
Walvax Biotechnology Company Limited operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Walvax Biotechnology Company Limited with three other companies in this sector in China: Beijing SL Pharmaceutical Co Ltd (2015 sales of 1.16 billion Chinese Renmimbi [US$170.70 million] of which 98% was Pharmaceuticals Industry), Tianjin Ringpu Bio Technology Co Ltd (792.32 million Chinese Renmimbi [US$116.95 million] of which 60% was Veterinary Biological Products), and Jinyu Bio-Technology Co Ltd (1.25 billion Chinese Renmimbi [US$183.80 million] of which 97% was Bio-Pharmaecutical).

Sales Analysis. During the year ended December of 2015, sales at Walvax Biotechnology Company Limited were 1.01 billion Chinese Renmimbi (US$148.39 million). This is an increase of 40.6% versus 2014, when the company's sales were 715.23 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Walvax Biotechnology Company Limited (and since 2010, sales have increased a total of 180%). Sales of Other saw an increase that was more than double the company's growth rate: sales were up 461.0% in 2015, from 3.70 million Chinese Renmimbi to 20.75 million Chinese Renmimbi. Walvax Biotechnology Company Limited also saw significant increases in sales in Vaccine Products Subcontract (up 67.5% to 578.92 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Walvax Biotechnology Company Limited
  Stock Performance Chart for Walvax Biotechnology Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 10.25
(Figures in Chinese Renmimbi)
1 Week -1.3%   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Walvax Biotechnology Company Limited Key Data:
  Ticker: 300142 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 1,005,385,890
(Year Ending Jan 2016).
Employees: 1,270
  Currency: Chinese Renmimbi Market Cap: 14,391,000,000
  Fiscal Yr Ends: December Shares Outstanding: 1,404,000,000
  Share Type: A Gu Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.